Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<keyword id="3658" type="General" weightage="100" keywordseo="india" source="Orion">India</keyword> on Tuesday recorded 3038 fresh cases of covid in the last 24 hours with the active caseload standing at 21,179. The COVID cases in India have seen an upward trend in the past few days with the daily fresh infections ranging between 2,994 on April 1 to 3,824 on April 2 and 3,641 on April 3 now dropped to 3038 in the last 24 hours. With 2,069 recoveries in the last 24 hours, total recoveries have increased to 4,41,77,204. India's recovery rate is currently at 98.76 per cent. The daily and weekly positivity rates are 1.84 per cent and 2.49 per cent respectively. A total of 1,894 doses were administered in the last 24 hours. Of the 92.20 crore total tests conducted so far, 1,64,740 tests were conducted in the last 24 hours. Under the Nationwide Vaccination Drive, India has so far administered 220.65 crore Covid-19 <keyword id="24209" type="General" weightage="80" keywordseo="vaccine" source="Orion">Vaccine</keyword> doses (95.20 crores <keyword id="7334317" type="General" weightage="80" keywordseo="second-dose" source="Orion">Second Dose</keyword> and 22.86 crores <keyword id="12813770" type="General" weightage="80" keywordseo="precaution-dose" source="Orion">Precaution Dose</keyword>), of which 9,497 doses were administered in the last 24 hours. In the wake of rising COVID cases in India, Union Health Minister Mansukh Mandaviya on Monday said that Omicron's sub-variant which is circulating in the country has not led to an increase in hospitalisations and there is no need to worry. The Minister said that there is a need to remain vigilant. "We need to remain alert but there is no need to worry. Currently, the sub-variant of Omicron which is circulating in the country hasn't increased hospitalisations," Mandaviya said. The Ministry of Health and Family Welfare has issued revised guidelines for Covid-19 in the wake of the surge of cases in the past week across the country. "Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease," revised guidelines said. "Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease," revised guidelines said. "Seek immediate medical attention if difficulty breathing, High-grade fever/ severe cough, particularly if lasting for more than 5 days. A low threshold is to be kept for those with any of the high-risk features," guidelines discussed and prepared in January said. Additionally, in moderate or severe diseases at high risk of progression, the guidelines recommend, "Consider <keyword id="8775508" type="General" weightage="80" keywordseo="remdesivir" source="Orion">Remdesivir</keyword> for up to 5 days (200 mg IV on day 1 followed by 100 mg IV OD for the next 4 days)". SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/virat-kohli-ms-dhoni-rohit-sharma-rule-brand-endorsements-in-indian-sports-industry/articleshow/99237494.cms">With 30 brands each, Kohli, Dhoni &amp; Rohit Sharma rule Indian sports endorsements</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/health/news/harsh-discipline-with-young-children-can-lead-to-lasting-mental-health-problems-says-new-study/articleshow/99238367.cms">Harsh discipline with young children can lead to lasting mental health problems says new study</a>

Remain alert says Union Health Minister as India records 3,038 fresh Covid-19 cases

As of now no second Covid-19 booster dose is required, said government sources amid an apparent increase in Covid-19 cases. "First we have to complete the booster drive in the country," said the government sources. India's active caseload currently stands at 2,582, with 134 new cases recorded in the last 24 hours, as per <keyword id="83655" type="General" weightage="80" keywordseo="union-health-ministry" source="Orion">Union Health Ministry</keyword> data. As per ministry data, a total of 220.11 cr vaccine doses (95.13 cr <keyword id="7334317" type="General" weightage="80" keywordseo="second-dose" source="Orion">Second Dose</keyword> and 22.41 cr <keyword id="12813770" type="General" weightage="80" keywordseo="precaution-dose" source="Orion">Precaution Dose</keyword>) have been administered so far under <keyword id="10580665" type="General" weightage="80" keywordseo="nationwide-vaccination-drive" source="Orion">Nationwide Vaccination Drive</keyword>. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/apps/news/series-creators-want-more-money-after-ads-appear-on-netflix/articleshow/96700323.cms">Series creators want more money after ads appear on Netflix</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/thelife/news/pope-benedict-xvi-a-man-at-odds-with-the-modern-world-who-leaves-a-legacy-of-intellectual-brilliance-and-controversy/articleshow/96699003.cms">Pope Benedict XVI: A man at odds with the modern world who leaves a legacy of intellectual brilliance and controversy</a>

No second Covid-19 booster dose required: Govt sources

<ul class="summary-list"><li><keyword id="92247" type="COMPANY" weightage="60" keywordseo="Johnson-Johnson">Johnson &amp; Johnson</keyword> <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> doses are on hold in <keyword id="28249" type="COMPANY" weightage="60" keywordseo="europe">Europe</keyword>, Africa, and <keyword id="6356687" type="LOCATION" weightage="60" keywordseo="canada">Canada</keyword>, the New York Times reported.</li><li>The doses were produced in a <keyword id="108481" type="COMPANY" weightage="60" keywordseo="Baltimore">Baltimore</keyword> plant around the time some batches were contaminated.</li><li><keyword id="2926245" type="COMPANY" weightage="60" keywordseo="Emergent-BioSolutions">Emergent BioSolutions</keyword> had to discard 15 million J&amp;J doses in March after the incident.</li></ul>Millions of doses of the Johnson &amp; Johnson vaccine are sitting unused across three continents as national regulators assess their safety, <a href="https://www.nytimes.com/2021/05/06/world/baltimore-vaccine-countries.html">The New York Times has reported</a>. Health officials across Europe, Africa and in Canada are reviewing batches of the J&amp;J vaccine manufactured at a Baltimore plant after some were <a href="https://www.businessinsider.com/factory-mixup-ruins-johnson-johnson-doses-nyt-2021-3">found in March to be contaminated</a> by portions of a harmless version of the virus that is used to make the <keyword id="6409874" type="COMPANY" weightage="60" keywordseo="astrazeneca">AstraZeneca</keyword> vaccine, which is also manufactured at the plant.Emergent BioSolutions, the biopharma company running the facility, had to dispose of up to <a href="https://www.businessinsider.com/factory-mixup-ruins-johnson-johnson-doses-nyt-2021-3">15 million doses</a> after the incident. An estimated six to nine million doses are on hold worldwide because they were manufactured during the time of the original contamination in February, according to the NYT. Regulators in the EU, Canada and <keyword id="6355117" type="LOCATION" weightage="60" keywordseo="south-africa">South Africa</keyword> have said there was no evidence to show the doses they received were contaminated, but they required further testing. Some doses from a batch produced at the site are being used in Europe. The Food and Drug Administration has not approved doses produced at Emergent's plant for use in the US, and did not say whether it had helped ship doses to other countries when asked by the NYT."In general, individual importing countries determine if a product meets that country's standards for importation," an FDA spokeswoman said in a statement to the NYT. The pause threatens to slow down the vaccination programs of countries relying on the J&amp;J vaccine, such as South Africa, which <a href="https://www.businessinsider.com/south-africa-halted-astrazeneca-covid-19-vaccine-2021-2">stopped using AstraZeneca's vaccine</a> in February after a study suggested it offered "minimal protection" against a <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword> variant spreading through the country. South Africa has one of the <a href="https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html">lowest vaccination rates of any country</a>, while Europe and Canada also use vaccines by AstraZeneca, Moderna and Pfizer-BioNTech to make up for a shortfall of J&amp;J shots.

Millions of Johnson & Johnson vaccine doses made at a Baltimore plant are reportedly being held across Europe, Africa, and Canada as a precaution

You Searched For "precaution dose" and got 3 results

Remain alert says Union Health Minister as India records 3,038 fresh Covid-19 cases

ANI

No second Covid-19 booster dose required: Govt sources

ANI

Millions of Johnson & Johnson vaccine doses made at a Baltimore plant are reportedly being held across Europe, Africa, and Canada as a precaution

Anna Cooban

Popular Keywords

Buying Guides